Contrast Enhanced Ultrasound Market 2024-2033: Production Analysis, Growth Strategy, Industry Insights And Major Players

The contrast enhanced ultrasound market size has grown strongly in recent years. It will grow from $1.93 billion in 2023 to $2.05 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to diagnostic accuracy and sensitivity, non-invasiveness and safety, rising incidence of liver diseases, global increase in aging population, growing preference for non-radiation techniques.

The contrast enhanced ultrasound market size is expected to see strong growth in the next few years. It will grow to $2.54 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rise in cardiovascular diseases, increasing applications in pediatric imaging, expanding role in gastrointestinal imaging, growing focus on precision medicine, integration with artificial intelligence. Major trends in the forecast period include continued technological innovations, advancements in ultrasound technology, expanding applications in oncology, integration with multimodal imaging, real-time quantitative assessment, pediatric applications.

Market Overview -
Contrast-enhanced ultrasound (CEUS) refers to a medical imaging technique that involves the use of contrast agents or microbubbles to enhance the visibility and clarity of ultrasound images. CEUS can be used to image blood perfusion in organs and measure blood flow rate in the heart and other organs.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13407&type=smp

The Role of Imaging Technology in Chronic Disease Forecasting
The rising prevalence of chronic diseases is expected to propel the growth of the contrast-enhanced ultrasound market going forward. Chronic diseases refer to long-term medical conditions that persist over an extended period and require ongoing medical management and care. Contrast-enhanced ultrasound helps provide real-time, detailed images of various chronic diseases, such as liver cirrhosis or vascular diseases associated with hypertension, contributing to more effective long-term management. For instance, in January 2023, according to a report published by the National Library of Medicine, a US-based agency, the number of individuals aged 50 years and older having one or more chronic illnesses is projected to rise by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020 in the United States. Therefore, the rising prevalence of chronic diseases will drive the growth of the contrast-enhanced ultrasound market.

Competitive Landscape -
Major companies operating in the contrast enhanced ultrasound market report are General Electric Company, Bayer AG, Bristol-Myers Squibb Company, Siemens Healthcare GmbH, Koninklijke Philips N.V., Daiichi Sankyo Company Limited, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., J.B. Chemicals and Pharmaceuticals Ltd., Canon Medical Systems, Lantheus Medical Imaging Inc., Guerbet, Bracco Diagnostic Inc., Esaote S.p.A., Trivitron Healthcare Pvt. Ltd., BK Medical Holding Company Inc., Hitachi Healthcare, Chison Medical Technology Co. Ltd., SANOCHEMIA Pharmazeutika GmbH, SuperSonic Imagine SA, FUJIFILM Visualsonics Inc., Leriva Pharma SA, Samsung Healthcare, Jodas Expoim Pvt Ltd., nanoPET Pharma GmbH, Alpinion Medical Systems, Acusphere Inc., ContextVision AB, Teratech Corporation, Solstice Pharmaceuticals B.V.

Advancements In Contrast-Enhanced Ultrasound (CEUS) Technology
Major companies operating in the contrast-enhanced ultrasound market are developing advanced technologies, such as super-resolution contrast-enhanced ultrasound (CEUS) technology, to improve the spatial resolution of CEUS images. The integration of advanced technologies in contrast-enhanced ultrasound enhances diagnostic capabilities, enabling healthcare professionals to obtain more detailed and accurate information about the anatomy, function, and perfusion of tissues and organs. For instance, in September 2023, Philips, a Netherlands-based company that develops and manufactures medical systems and consumer electronics products, launched Philips Microvascular Imaging Super Resolution Contrast-Enhanced Ultrasound (CEUS), a super-resolution CEUS technology that uses advanced signal processing algorithms to improve the spatial resolution of CEUS images. It helps to provide high-resolution images of blood vessels and other structures to diagnose and treat a variety of diseases, including cancer, liver disease, and vascular diseases.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/contrast-enhanced-ultrasound-global-market-report

Key Segments -
The contrast enhanced ultrasound market covered in this report is segmented -
1) By Product: Equipment, Contrast Agent
2) By Technology: Non-targeted, Targeted
3) By Application: Hospitals, Clinics, Other Applications

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

This release was published on openPR.